<DOC>
	<DOCNO>NCT02541123</DOCNO>
	<brief_summary>The primary objective clinical trial evaluate effect time level Ubiquitin C-terminal Hydrolase-L1 ( UCH-L1 ) Glial Fibrillary Acidic Protein ( GFAP ) biomarker level population head injured subject age 18 present acutely Glasgow Coma Scale score 13-15 well group uninjured control subject .</brief_summary>
	<brief_title>Evaluation Biomarker Kinetics After Mild Brain Injury Trauma</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Head Injured Cohorts At least 18 year age screening . Presented suspect traumatically induce head injury , result insult head external force . Workup include head CT scan , part clinical emergency care CT result ( CTpositive CTnegative acute intracranial lesion ) base local neuroradiologist 's review available study staff . CT scan CT report use determine eligibility must available . Glasgow Coma Scale score 1315 time Informed Consent . Weighs least 110lbs ( 50kg ) , donate blood within last 8 week , anemic blood disorder require routine transfusion . First study blood sample able collect cohort close enrollment Able participate 11 day follow head injury . Subject legal representative willing undergo Informed Consent process prior enrollment study . FOR CT NEGATIVE COHORTS ONLY : Subject must experience Loss Consciousness ( LOC ) &lt; 30 minute , Alteration Consciousness ( AOC ) , Posttraumatic amnesia ( PTA ) follow suspect head injury AND expect admitted hospital , remain hospital least 24 hour order complete Visit 1 blood draw Head Injured Cohorts Participating interventional , therapeutic clinical study may affect result study ( observational study would acceptable ) . Time injury determine . Primary diagnosis ischemic hemorrhagic stroke . Venipuncture feasible Neurodegenerative disease neurological disorder include dementia , Parkinson 's disease , multiple sclerosis , seizure disorder , brain tumor . History neurosurgery within last 30 day . Administration blood transfusion head injury prior study blood draw . Female pregnant lactating . Subject otherwise determine Investigator unsuitable candidate participation . Control Cohort Inclusion Criteria At least 18 year age screen Weighs least 110lbs ( 50kg ) , donate blood within last 8 week , anemic blood disorder require routine transfusion . Healthy chronic acute medical , neurologic , psychiatric condition ( best knowledge ) . Able participate 5 hour follow first study blood draw . Willing undergo Informed Consent process prior enrollment study . Subject able enrol control cohort yet close enrollment Control Cohort Exclusion Criteria Participating interventional , therapeutic clinical study may affect result study ( observational study would acceptable ) . Subject sustain significant bodily injury within past week . Venipuncture feasible ( i.e. , skin integrity compromise venipuncture site , blood vessel calcification ( i.e. , IV drug user , advanced atherosclerosis ) upper limb miss ( congenital amputee ) ) . Neurodegenerative disease neurological disorder include dementia , Parkinson 's disease , multiple sclerosis , seizure disorder , brain tumor . Female pregnant lactate History neurosurgery within last 30 day . Subject otherwise determine Investigator unsuitable candidate participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Traumatic Brain Injury</keyword>
	<keyword>Head Injury</keyword>
</DOC>